Cognitive training in Parkinson disease: A systematic review and meta-analysis

Neurology

Volumn 85, Issue 21, 2015, Pages 1843-1851

  Leung, Isabella H K ^a   Walton, Courtney C ^b   Hallock, Harry ^a   Lewis, Simon J G ^b   Valenzuela, Michael ^a   Lampit, Amit ^a  

^a Regenerative Neuroscience Group   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; COGNITION; COGNITIVE THERAPY; COGNITIVE TRAINING; DAILY LIFE ACTIVITY; DEPRESSION; DEPTH PERCEPTION; EXECUTIVE FUNCTION; HUMAN; META ANALYSIS; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; WORKING MEMORY; AGED; COGNITION DISORDERS; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACTIVITIES OF DAILY LIVING; AGED; COGNITION; COGNITION DISORDERS; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84947913712     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002145     Document Type: Review

References (36)

1. Burn D, Weintraub D, Robbins T. Introduction: the importance of cognition in movement disorders. Mov Dis-ord 2014;29:581-583.
2. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Dis-ord 2012;27:349-356.
3. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
4. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012;11:697-707.
5. Seppi K, Weintraub D, Coelho M, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011;26(suppl 3): S42-S80.
6. Mowszowski L, Batchelor J, Naismith SL. Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? Int Psychogeriatr 2010;22:537-548.
7. Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med 2014;11:e1001756.
8. Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature. Am J Geriatr Psychiatry 2015;23:335-359.
9. Walton CC, Shine JM, Mowszowski L, Naismith SL, Lewis SJ. Freezing of gait in Parkinson's disease: current treatments and the potential role for cognitive training. Restor Neurol Neurosci 2014;32:411-422.
10. Hindle JV, Petrelli A, Clare L, Kalbe E. Nonpharmaco-logical enhancement of cognitive function in Parkinson's disease: a systematic review. Mov Disord 2013;28:1034-1049.
11. Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis 2012;2012:512892.
12. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6: e1000100.
13. Strauss EH, Sherman EMS, Spreen OA, editors. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. Oxford: Oxford University Press; 2006.
14. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley Online Library; 2008.
15. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating qual ity of randomized controlled trials. Phys Ther 2003;83: 713-721.
16. Borenstein M, Hedges L, Higgins JP, Rothstein HR. Introduction to Meta-analysis. Chichester: Wiley; 2009.
17. Gleser LJ, Olkin I. Stochastically dependent effect sizes. In: Cooper H, Hedges L, Valentine J, editors. The Handbook of Research Synthesis and Meta-analysis, 2nd ed. New York: Russell Sage Foundation; 2009: 357-376.
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Mea suring inconsistency in meta-analyses. BMJ 2003;327: 557-560.
19. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
20. Cerasa A, Gioia MC, Salsone M, et al. Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci 2014;35:1173-1180.
21. Edwards JD, Hauser RA, O'Connor ML, Valdes EG, Zesiewicz TA, Uc EY. Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology 2013;81:1284-1290.
22. Pena J, Ibarretxe-Bilbao N, Garcia-Gorostiaga I, Gomez-Beldarrain MA, Diez-Cirarda M, Ojeda N. Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 2014;83:2167-2174.
23. Paris AP, Saleta HG, de la Cruz Crespo Maraver M, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Mov Disord 2011; 26:1251-1258.
24. Petrelli A, Kaesberg S, Barbe MT, et al. Effects of cognitive training in Parkinson's disease: a randomized controlled trial. Parkinsonism Relat Disord 2014;20: 1196-1202.
25. Pompeu JE, Mendes FA, Silva KG, et al. Effect of Nintendo Wii-based motor and cognitive training on activities of daily living in patients with Parkinson's disease: a randomised clinical trial. Physiotherapy 2012;98:196-204.
26. Sammer G, Reuter I, Hullmann K, Kaps M, Vaitl D. Training of executive functions in Parkinson's disease. J Neurol Sci 2006;248:115-119.
27. Zimmermann R, Gschwandtner U, Benz N, et al. Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training. Neurology 2014;82:1219-1226.
28. Burdick DJ, Cholerton B, Watson GS, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 2014;29: 1258-1264.
29. Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351-6356.
30. Robbins TW, Cools R. Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective. Mov Disord 2014;29:597-607.
31. Kehagia AA, Barker RA, Robbins TW. Neuropsychologi-cal and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9:1200-1213.
32. Karayanidis F. Parkinson's disease: a conceptualization of neuropsychological deficits within an information-processing framework. Biol Psychol 1989;29:149-179.
33. Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991;41:365-369.
34. Naismith SL, Mowszowski L, Diamond K, Lewis SJ. Improving memory in Parkinson's disease: a healthy brain ageing cognitive training program. Mov Disord 2013;28:1097-1103.
35. Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol 2011;2:82.
36. Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. J Aging Res 2012;2012: 235765.